Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyoshi Nishikawa

Showing results (101-110 of 197) with videos related to

Pageof 20
Sort By:
European Journal of Immunology|February 26, 2013
Overcoming regulatory T-cell suppression by a lyophilized preparation of Streptococcus pyogenesMichiko Hirayama, Hiroyoshi Nishikawa, Yasuhiro Nagata, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2003
CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responsesHiroyoshi Nishikawa, Takuma Kato, Koji Tanida, et al.
European Journal of Immunology|December 18, 2009
Thioredoxin suppresses airway inflammation independently of systemic Th1/Th2 immune modulationMie Torii, Linan Wang, Ning Ma, et al.
Blood|February 11, 2012
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphomaHiroyoshi Nishikawa, Yuka Maeda, Takashi Ishida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2019
Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor ImmunityTokiyoshi Tanegashima, Yosuke Togashi, Koichi Azuma, et al.
Experimental Hematology|December 22, 2012
Manipulation of human early T lymphopoiesis by coculture on human bone marrow stromal cells: potential utility for adoptive immunotherapyBing Liu, Kohshi Ohishi, Yuki Orito, et al.
Cancer Immunology Research|April 27, 2026
Lenvatinib combined with PD-1 blockade therapy benefits gastric cancers through immunosuppressive macrophage modulationNina Yi-Tzu Lin, Hirotomo Machiyama, Akihito Kawazoe, et al.
International Immunology|December 24, 2019
The potential application of PD-1 blockade therapy for early-stage biliary tract cancerKumiko Umemoto, Yosuke Togashi, Yasuhito Arai, et al.
Life Sciences|September 17, 2022
Molecular hydrogen has a positive impact on pregnancy maintenance through enhancement of mitochondrial function and immunomodulatory effects on T cellsChieko Aoki, Kenji Imai, Teruyuki Mizutani, et al.
Immunity|July 9, 2020
An Oncogenic Alteration Creates a Microenvironment that Promotes Tumor Progression by Conferring a Metabolic Advantage to Regulatory T CellsShogo Kumagai, Yosuke Togashi, Chika Sakai, et al.
Pageof 20

Showing results (101-110 of 197) with videos related to

Sort By:
Pageof 20
European Journal of Immunology|February 26, 2013
Overcoming regulatory T-cell suppression by a lyophilized preparation of Streptococcus pyogenesMichiko Hirayama, Hiroyoshi Nishikawa, Yasuhiro Nagata, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2003
CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responsesHiroyoshi Nishikawa, Takuma Kato, Koji Tanida, et al.
European Journal of Immunology|December 18, 2009
Thioredoxin suppresses airway inflammation independently of systemic Th1/Th2 immune modulationMie Torii, Linan Wang, Ning Ma, et al.
Blood|February 11, 2012
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphomaHiroyoshi Nishikawa, Yuka Maeda, Takashi Ishida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2019
Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor ImmunityTokiyoshi Tanegashima, Yosuke Togashi, Koichi Azuma, et al.
Experimental Hematology|December 22, 2012
Manipulation of human early T lymphopoiesis by coculture on human bone marrow stromal cells: potential utility for adoptive immunotherapyBing Liu, Kohshi Ohishi, Yuki Orito, et al.
Cancer Immunology Research|April 27, 2026
Lenvatinib combined with PD-1 blockade therapy benefits gastric cancers through immunosuppressive macrophage modulationNina Yi-Tzu Lin, Hirotomo Machiyama, Akihito Kawazoe, et al.
International Immunology|December 24, 2019
The potential application of PD-1 blockade therapy for early-stage biliary tract cancerKumiko Umemoto, Yosuke Togashi, Yasuhito Arai, et al.
Life Sciences|September 17, 2022
Molecular hydrogen has a positive impact on pregnancy maintenance through enhancement of mitochondrial function and immunomodulatory effects on T cellsChieko Aoki, Kenji Imai, Teruyuki Mizutani, et al.
Immunity|July 9, 2020
An Oncogenic Alteration Creates a Microenvironment that Promotes Tumor Progression by Conferring a Metabolic Advantage to Regulatory T CellsShogo Kumagai, Yosuke Togashi, Chika Sakai, et al.
Pageof 20